Atlas Trials

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Clinical trial NCT07183293 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07183293
Sponsor
Xiamen Humanity Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HBV-related Liver Cirrhosis
Start date
2025-10-01
Primary completion
2027-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.